Loss of ATM/Chk2/p53 Pathway Components Accelerates Tumor Development and Contributes to Radiation Resistance in Gliomas
Massimo SquatritoDepartment of Cancer Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USACameron BrennanHuman Oncology Pathology Program, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USAKarim Y. HelmyBrain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USAJason T. HuseDepartment of Pathology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USAJohn H.J. PetriniDepartment of Molecular Biology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USAEric C. HollandBrain Tumor Center, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
2010en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0